|
|
||||||||
AJP - Renal Physiology, Vol 265, Issue 5 624-F633, Copyright © 1993 by American Physiological Society
ARTICLES |
A. Flyvbjerg, S. Nielsen, M. I. Sheikh, C. Jacobsen, H. Orskov and E. I. Christensen
Institute of Experimental Clinical Research, Aarhus Kommunehospital, Denmark.
The aim of the present study was to quantify and compare the luminal and basolateral binding and uptake of 125I-labeled insulin-like growth factor I (IGF-I) by means of 1) isolated, perfused, proximal tubules combined with electron microscope autoradiography and 2) luminal and basolateral membrane vesicles from rabbit proximal tubules. 125I-IGF-I was added to isolated perfused proximal tubules for 30 min in concentrations of 1.6-3.9 micrograms/l to either the perfusate or the bath. The luminal and basolateral uptake in 30 min averaged 447 and 410 fg/mm, respectively. About 20% of the luminally absorbed IGF-I was digested. Addition of excess unlabeled IGF-I (10(-7) M) to the bath produced complete inhibition of the basolateral binding/uptake, whereas no inhibition of the luminal uptake was seen. Electron microscope autoradiography showed that IGF-I after luminal endocytic uptake to a large extent was transported into lysosomes. After basolateral exposure the major portion of the grains was found over the basolateral cell membrane; however, a significant amount was located over endocytic vacuoles and lysosomes in both apical and basal parts of the cells. In both luminal and basolateral membrane vesicles, single-class, high-affinity binding sites for IGF-I were found with dissociation constants of 6.3 and 5.7 nM, respectively. Specific binding capacities averaged 2.7 and 25.7 pmol IGF-I/mg protein in luminal and basolateral vesicles. The biochemical data suggest an asymmetric distribution of specific IGF-I receptors in the luminal and basolateral membranes, with a greater abundance of receptors in the latter. The extensive basolateral endocytic binding/uptake of IGF-I compared with that of the luminal in isolated perfused tubules differs considerably from the processing of other peptide hormones.
This article has been cited by other articles:
![]() |
N. Obermuller, B. Kranzlin, W. F. Blum, N. Gretz, and R. Witzgall An endocytosis defect as a possible cause of proteinuria in polycystic kidney disease Am J Physiol Renal Physiol, February 1, 2001; 280(2): F244 - F253. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Symon, S. Fuchs, Y. Agmon, O. Weiss, I. Nephesh, R. Moshe, M. Brezis, A. Flyvbjerg, and I. Raz The endogenous insulin-like growth factor system in radiocontrast nephropathy Am J Physiol Renal Physiol, March 1, 1998; 274(3): F490 - F497. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Piron, I. Leonard, D. Nonclercq, G. Toubeau, P. Falmagne, J.-A. Heuson-Stiennon, and G. Laurent In vitro demonstration of a mitogenic activity in renal tissue extracts during regenerative hyperplasia Am J Physiol Renal Physiol, February 1, 1998; 274(2): F348 - F357. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |